Ready-to-eat ribs from Canada were recalled for not being inspected in the U.S.

ribs

Macgregors Meat and Seafood Ltd, in Woodbridge, Ontario, Canada, is recalling approximately 2,745 pounds of frozen, ready-to-eat pork products that were not presented for import reinspection into the United States, according to USDA’s Food Safety and Inspection Service (FSIS).

The following products are subject to the recall:

  • 1.5-lb. cartons containing “44TH Street Slow Cooked BABY BACK RIBS MAPLEWOOD SMOKED SAUCE” with Julian dates 3453 and 0154 printed on the side of the immediate package. The product is packed in cases marked with Cert. No. Cert 043436, Production Date 3453 with USE BY 2024 DE 10 and Production Date 0154 with USE BY 2025 JA 14.
  • 1.5-lb. cartons containing “44TH Street Glazed, Slow Cooked BABY BACK RIBS HONEY GARLIC SAUCE” with Julian dates 1453 and 1593 printed on the side of the immediate package. The product is packed in cases marked with Cert. No. Cert 043436, Production Date 1453 with USE BY 2024 MA 24 and Production Date 1593 with USE BY 2024 JN 07.

The products subject to recall bear Canadian establishment number 566 printed inside the Canadian inspection mark on the label. These items were shipped to retail locations and restaurants in Indiana, Kentucky, Michigan, New York, Ohio, and Pennsylvania.

The lack of U.S. inspection was discovered when the firm notified FSIS that the product was not presented for FSIS import reinspection.

There have been no confirmed reports of illness or adverse reactions due to consumption of these products. Anyone concerned about an illness or reaction should contact a healthcare provider.

FSIS is concerned that some products may be in consumer and restaurant freezers. Consumers who have purchased these products are urged not to consume them. Restaurants are urged not to serve these products. The products should be thrown away or returned to the place of purchase.

FSIS routinely conducts recall effectiveness checks to verify that recalling firms notify their customers of the recall and that steps are taken to ensure the product is no longer available to consumers. When available, the retail distribution list(s) will be posted on the FSIS website at www.fsis.usda.gov/recalls.


(To sign up for a free subscription to Food Safety News, 
click here.)

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Here Is the Right Way to Do Kegel Exercises thumbnail

Here Is the Right Way to Do Kegel Exercises

Doing Kegel exercises is a bit like flossing—it’s a tiny little thing that you know you should be doing regularly to keep a crucial part of your body healthy, but for some reason it just completely slips your mind until the next time someone asks you about your track record. (Or, more likely, the next…
Read More
The Emotional Effects of OAB thumbnail

The Emotional Effects of OAB

Please enable cookies. Error 1005 Ray ID: 88cdb7e60f783e27 • 2024-06-01 08:08:53 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 88cdb7e60f783e27 • Your IP: 185.124.111.116 •
Read More
Voice-control smart devices might hinder kids' social and emotional development, says expert thumbnail

Voice-control smart devices might hinder kids’ social and emotional development, says expert

Credit: Unsplash/CC0 Public Domain Voice-control smart devices, such as Alexa, Siri, and Google Home might hinder children's social and emotional development, argues an expert in the use of artificial intelligence and machine learning in health care, in a viewpoint published online in the Archives of Disease in Childhood. These devices might have long-term effects by
Read More
Tirofiban Does Not Improve Outcomes of EVT in Stroke thumbnail

Tirofiban Does Not Improve Outcomes of EVT in Stroke

Adjunctive treatment with intravenous (IV) tirofiban does not improve clinical outcomes in patients with large-vessel occlusion (LVO) stroke who undergo endovascular treatment (EVT) within 24 hours of symptom onset, new data suggest. In a randomized, phase 3 trial of more than 900 patients with acute ischemic stroke who underwent EVT, the median Modified Rankin Scale…
Read More
Index Of News
Total
0
Share